Skip to main content
Premium Trial:

Request an Annual Quote

Serologicals, Cellumen to Develop and Sell Cytotoxicity Panel and Services

NEW YORK, Feb. 7 (GenomeWeb News) - Serologicals has signed an agreement with Cellumen to commercialize a cytotoxicity profiling panel and services, Serologicals said today.


The system will be designed with cellular assay reagents from Serologicals' Chemicon and Upstate units and with Cellumen's system cell biology approach, the company said in a statement.


Chemicon will focus on the development and production of assays and panels, while Cellumen will focus on their use on profiling services.


The companies will market the products jointly.


No additional details were provided.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.